Skip to content

9 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Nov 2026

Convergence of Cerebrospinal Fluid Neuronal Biomarker Burden and MRI Lesion Pattern and Its Association With Short‐Term Outcome in Neuroinfectious Diseases

ABSTRACT Background Neuroinfectious diseases (NDs) are potentially treatable conditions associated with substantial morbidity, but their clinical course remains difficult to predict. While specific MRI patterns are characteristic of distinct aetiologies, their prognostic value remains poorly investigated. Cerebrospinal...

L. D'Anna, D. Erhart, F. Konen et al. · 0 citations
Oct 2026

Serum β-synuclein predicts dementia conversion and mortality beyond amyloid-β and phospho-tau.

Serum β-synuclein provided prognostic information largely independent of CSF Aβ42/Aβ40 across all endpoints and of pTau181 for survival outcomes, while sharing substantial prognostic variance beyond CSF biomarkers.

T. Oberstein, Julian Schwarz, Laura Rudtke et al. · 0 citations
Review Open access Oct 2026

Intravenous and intra-arterial thrombolysis for acute ischemic stroke following interventional cardiac procedures: A systematic review and narrative synthesis

Acute ischemic stroke is a rare but potentially devastating complication of interventional cardiac procedures, and evidence on thrombolysis remains limited. To systematically review intravenous and intra-arterial thrombolysis (IVT and IAT) for ischemic stroke during or after cardiac procedures, focusing on n...

L. D'Anna, G. Prandin, S. Abu-Rumeileh et al. · 0 citations
Open access Nov 2026

Beyond anticoagulation: Statin therapy and 90-day mortality after breakthrough ischemic stroke in atrial fibrillation

Secondary stroke prevention in patients with atrial fibrillation (AF) who experience an ischemic stroke (IS) despite oral anticoagulation remains challenging, and strategies have focused on antithrombotic optimization or left atrial appendage occlusion. Adjunctive statin therapy might reduce early vascular risk and...

G. Merlino, R. Ornello, L. D'Anna et al. · 0 citations
Open access Oct 2026

Plasma β‐synuclein associates with hippocampal synaptic density measured with [11C]UCB‐J PET and plasma tau markers in Alzheimer's disease

Abstract INTRODUCTION Plasma β‐synuclein is a promising blood‐based synaptic biomarker, but relationships with synaptic density as indicated by [11C]UCB‐J positron emission tomography (PET), and blood biomarkers of Alzheimer's disease (AD) pathology, neurodegeneration, and astrocyte activation need further characteriza...

Darby C. Peter, Max J. McLachlan, A. DiFilippo et al. · 0 citations
Sep 2026

Whole-body quantitative muscle MRI in myotonic dystrophy type 2: a sensitive tool for pattern recognition, disease stratification and objective assessment of clinical severity

Background Myotonic dystrophy type 2 (DM2) is a frequent yet underdiagnosed muscle disorder. Although muscle MRI is increasingly used in neuromuscular disorders, there is an overt lack of evidence regarding its role in DM2. This study aimed to characterise whole-body muscle involvement using semiquantitative and quanti...

Alexander Mensch, M. Heuschen, L. Barba et al. · 0 citations
Open access Sep 2026

Role of Thrombectomy Technique in Alteplase Bridging Intravenous Thrombolysis for Basilar Artery Occlusion

Background Endovascular treatment (EVT) is the standard of care for acute basilar artery occlusion (BAO) although the role of bridging intravenous thrombolysis (IVT) with alteplase prior to EVT remains debated. Whether the effect of bridging IVT differs across EVT techniques has not been systematically assessed. Method...

Muhammad Jaffar, K. Ahmed, S. Abu-Rumeileh et al. · 0 citations
Open access Sep 2026

Changes in serum β‐synuclein precede blood biomarkers of Alzheimer pathology in Down syndrome

There is a need for early, objective markers of Alzheimer's disease (AD)‐related synapse dysfunction in adults with Down syndrome (DS). The presynaptic protein β‐synuclein is elevated in the blood of adults with DS. This study evaluates the positioning of these changes relative to changes in pathophysiological blood bi...

Alba Cervantes González, A. Morcillo-Nieto, Sara Serrano et al. · 0 citations
Review Open access Sep 2026

Progress towards a biotypic biomarker profile for amyotrophic lateral sclerosis-frontotemporal spectrum disorders.

An international workshop was convened in London, Canada in 2025 to review the evidence for existing or evolving biomarkers suitable for the detection of either ALS or FTD pathobiology prior to phenoconversion and/or predict phenoconversion in at risk individuals.

Michael J. Strong, Neil S. Donison, A. Al-Chalabi et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.